PRESENTATION
MESSAGE FROM THE ORGANIZING COMMITTEE
GERAL
6 – ONCOTYPE DX® IN THE SISTEMA ÚNICO DE SAÚDE DO BRASIL (SUS): RESULT OF 125 CASES
9 – INFLUENCE OF THE SURGICAL CLIP ON BREAST, HEART AND LUNG VOLUMES OF PATIENTS SUBMITTED TO BOOST DURING THE PLANNING OF BREAST CANCER RADIOTHERAPY, ACCORDING TO ONCOPLASTIC SURGERY
10 – ONCOPLASTIC SURGERY IN BREASTCONSERVATIVE TREATMENT: PATIENT PROFILE AND IMPACT ON QUALITY OF LIFE
COMMENTED POSTER
25 – ANALYSIS OF EPIGENETIC MOLECULES SIRT2 E SIRT6 IN BREAST CANCER SUBTYPES
31 – INVASIVE APPROACHES IN BENIGN BREAST TUMORS IN BRAZIL
E-POSTER
32 – TELOMERASE POLYMORPHISM AND BREAST CANCER
36 – STRATEGIES OF GUIDELINES IMPLEMENTATION FOR THE BREAST CANCER EARLY DETECTION IN BRAZIL
37 – SEXUAL DYSFUNCTION AMONG WOMEN WITH BREAST CANCER DIAGNOSTIC: DESCRIPTIVE STUDY
38 – MICRO-RNA 21 ACTING AS AN ONCOMIR ON HER2 POSITIVE BREAST CANCER: A META-ANALYSIS
39 – BREAST CANCER SURVIVAL: A HOSPITAL REGISTRY-BASED RETROSPECTIVE COHORT OF SÃO PAULO, BRAZIL
41 – STANDARD BREAST-CONSERVING VERSUS ONCOPLASTIC SURGERY: A LOCOREGIONAL RECURRENCE COMPARISON
48 – INSTRUCTION LEVEL AND SKIN COLOR EXPRESSED IN MAMMOGRAMS IN THE STATE OF GOIÁS IN 2013
49 – CLINICAL AND MOLECULAR EVALUATION OF MICROCALCIFICATIONS CLASSIFIED AS BIRADS® 4 AND 5
57 – IMPACT OF REFERENCE CENTER ON BREAST CANCER IN CAPITAL CITY
61 – DUCTAL CARCINOMA IN SITU OF THE BREAST: FIRST ANALYSIS OF 167 CASES
62 – COULD PRIMARY TUMOR RESECTION IMPROVE SURVIVAL IN METASTATIC BREAST CANCER?
64 – ACCESSIBILITY TO BREAST CANCER TREATMENT AND BARRIERS TO HEALTH ASSISTANCE
65 – THE IMPORTANCE OF EARLY DETECTION OF DEPRESSION IN POST-MASTECTOMY PATIENTS
67 – IMPLICATIONS OF ALTERNATIVE TREATMENT IN BREAST CANCER
68 – ELASTOGRAPHY: THE IMPACT OF THE USE OF THE TOOL FOR THE CHARACTERIZATION OF BREAST LESIONS
72 – HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF 22 CASES OF MALE BREAST CANCER
73 – PROFILE OF LOCOREGIONAL RECURRENCE AND DISTANT METASTASIS OF BREAST CANCER IN BRAZILIAN WOMEN
74 – PROFESSIONAL APPROACH ON WOMEN WITH BREAST CANCER: A LEARNING PROCESS
75 – AVALIAÇÃO CLINICA E CIRÚRGICA DE GINECOMASTIA EM PACIENTES DO SUS
78 – MONITORING OF RISK FACTORS IN FAMILY MEMBERS OF PATIENTS WITH BREAST CANCER
79 – IMPORTANCE OF HEALTH AGENTS IN THE PREVENTION OF BREAST CANCER
80 – THE IMPORTANCE OF SOCIAL SUPPORT AS A DRIVER OF IMPROVEMENT IN THE TREATMENT OF BREAST CANCER
81 – LITERATURE REVIEW: PSYCHIATRY IN PATIENTS WITH BREAST CANCER
82 – MAMMOGRAPHY AND BREAST CANCER: ANALYSIS OF A PROVEN SCREENING METHOD
83 – THE IMPORTANCE OF EXERCISE IN THE PREVENTION OF BREAST CANCER
84 – UNILATERAL PAGET’S DISEASE IN YOUNG ADULT: A CASE REPORT
85 – NURSING ASSISTANCE TO PATIENTS WITH BREAST CANCER
86 – NURSING ASSISTANCE IN THE TREATMENT OF BREAST CANCER TO VULNERABILITIES AND CHALLENGES
87 – THE COUNSEL OF BREAST CANCER IN THE FAMILY HEALTH STRATEGY
88 – THE RELATIONSHIP BETWEEN THE CONSUPTION OF ISOFLAVONES AND THE DEVELOPMENT OF BREAST CANCER
89 – VEGETARIAN DIET AND BREAST CANCER RISK: WHAT IS THE RELATION?
90 – POST-OPERATIVE OUTCOME IN ELECTIVE SURGERIES
92 – BREAST CANCER AND YOUR RELATION WITH SEXUAL HORMONES
93 – BRCA2 C.156_157 INSALU MUTATION IN A MALE BRAZILIAN PATIENT WITH BREAST CANCER
94 – OCULAR AND ORBITAL METASTASIS IN BREAST CANCER: CASE SERIES REPORT
95 – UNUSUAL METASTASIS OF BREAST CANCER: REPORT OF THREE CASES
96 – BENIGN BREAST LUMPS: SYSTEMATIC REVIEW OF DIAGNOSIS AND CONDUCT
I – Volume 29, Supplement 1, 2019
See full edition